Jim Simons Organogenesis Holdings Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 795,700 shares of ORGO stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
795,700
Previous 807,100
1.41%
Holding current value
$2.61 Million
Previous $2.29 Million
2.84%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ORGO
# of Institutions
121Shares Held
60.9MCall Options Held
28.8KPut Options Held
27.9K-
Morgan Stanley New York, NY11.6MShares$38 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT11.5MShares$37.8 Million3.27% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$16.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$11.7 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.07MShares$10.1 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $429M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...